Industrials · Industrial Conglomerates · US stock · price as of 16 Oct 2026
Key indicators
Price
$130.45
52-week range
$95.66 – $156.04
Market cap
$17.8B
P/E (trailing)
823.6×
EV / EBITDA
21.1×
Free-cash-flow yield
–
Dividend yield
0.9%
Revenue (last 12 months)
$7.0B
Revenue growth (3y a year)
−19.3%
Operating margin
6.8%
Return on invested capital
2.8%
Net debt / EBITDA
1.5×
Fair value
Blended fair value$8.45 range $7 – $10
Versus priceData under review+0% to fair value
Peer multiples
$7.49
Fundamentals-adjusted multiple
$7.25
10-year DCF (market-scaled)
$10.61
Earnings power value (floor, not blended)
$13.32
Model uncertainty
High
X-Ray Score
18/ 100 · Medium confidence · ahead of 0% of sector peers
Valuation4
Growth22
Profitability7
Financial health48
Dividends13
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
Executive summary
DuPont is a materials science and technology company that supplies specialty products to industrial and healthcare markets. Its offerings include water filtration and purification technology, construction and building materials such as Tyvek, and materials used in medical devices and healthcare packaging. Customers include building product makers, water treatment operators, device makers and industrial manufacturers. The company is organised around a small number of specialty businesses.
Supplying engineered materials and technologies to manufacturers generated revenue of $7.0 billion over the last twelve months. Revenue has changed at -19.3% a year across the last three years, a steep decline. The operating margin is 6.8%, the business earns 3% on the capital invested in it, and net debt is 1.5 times EBITDA. The dividend yield is 0.9%.
StocksXray gives DuPont de Nemours, Inc. an X-Ray Score of 18 out of 100 (medium confidence), ahead of 0% of the S&P 500 stocks in its sector. Its strongest lens is financial health (48) and its weakest is valuation (4).
Our fair value blend is $8.45 (range $7.08 to $10.13). At $130.45 the stock trades 1,444% above that blend, so the label is "Data under review" with high model uncertainty. Fair value is a range, not a price target.
XStocksXray
DuPont de Nemours, Inc. (DD)
Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months
FY2021
FY2022
FY2023
FY2024
FY2025
Now
Price
$92.43
$80.09
$91.58
$92.54
$119.12
$130.45
Market cap
$50.3B
$40.0B
$41.2B
$38.8B
$49.9B
$17.8B
P/E
7.8×
6.8×
97.4×
55.1×
–
823.6×
EV / revenue
4.8×
3.3×
7.1×
6.6×
7.7×
2.8×
EV / EBITDA
23.4×
16.9×
156.3×
59.3×
62.1×
21.2×
Price / free cash flow
33.7×
–
–
–
–
–
Free-cash-flow yield
3.0%
−0.2%
–
–
–
–
Price / book
1.9×
1.5×
1.7×
1.7×
3.6×
1.3×
Dividend yield
1.30%
1.65%
1.57%
1.64%
1.20%
0.92%
Fundamentals checklist ● 2 Good · ● 3 Average · ● 7 Bad · each check graded against the sector
Risk models
Altman Z score-0.7×Bad
Piotroski F-Score6 of 9Average
Growth
Revenue growth (3y)−19.3%Bad
Growth consistency70%Average
Balance sheet
Current ratio2.4×Good
Net debt / EBITDA1.5×Average
Interest coverno interest costGood
Valuation
Fair value vs price0.1×Bad
EBIT / EV yield2.4%Bad
Profitability
Return on invested capital2.8%Bad
Operating margin6.8%Bad
Gross profitability11.7%Bad
XStocksXray
DuPont de Nemours, Inc. (DD)
Financials US$ millions, from SEC filings; last column is the last twelve months
Income statement
FY21
FY22
FY23
FY24
FY25
LTM
Revenue
12,566
13,017
6,614
6,719
6,849
6,988
Gross profit
4,595
4,615
2,172
2,220
2,363
2,455
Operating income
1,444
1,448
-279
117
200
472
Net income
6,467
5,868
423
703
88
55
Diluted EPS ($)
11.89
11.75
0.94
1.68
-1.86
0.16
Free cash flow
1,493
-74
–
–
–
–
Gross margin
36.6%
35.5%
32.8%
33.0%
34.5%
35.1%
Operating margin
11.5%
11.1%
−4.2%
1.7%
2.9%
6.8%
Net margin
51.5%
45.1%
6.4%
10.5%
1.3%
0.8%
Balance sheet
FY21
FY22
FY23
FY24
FY25
LTM
Total assets
45,707
41,355
38,552
36,636
21,575
21,061
Cash
1,972
3,662
2,392
1,792
715
1,740
Total debt
10,932
8,074
7,800
7,171
3,194
3,125
Equity
26,433
26,569
24,279
23,350
13,919
13,769
Dividend per share ($)
1.20
1.32
1.44
1.52
1.43
-1.46
Revenue and net income US$ billions: navy revenue, teal net income
Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.